Fulgent Genetics, Inc.
corporate_fare Company Profile
Fulgent Genetics, Inc. (NASDAQ:FLGT) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 17 items for FLGT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 17 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for FLGT spans 10-Q, 8-K, SCHEDULE 13D/A, DEFA14A.
Recent high-impact activity:
- Fulgent 10-Q: Q3 Revenue $90.4M, Gross Margin 35%, Nine-Month Loss $67.5M
- Fulgent Q3 Revenue $90.4M, GAAP Loss $(0.48)/Share; FY26 Loss Guidance $46-50M
- Fulgent Genetics Posts 48-Cent Loss Per Share in Third Quarter
- Fulgent Genetics Q2 Losses Deepen as Billing Woes Crush Margins; Cash Burn Accelerates
- Fulgent Genetics Q2 Revenue Misses, Guidance Slashed as Gross Margin Halves
Financial Snapshot
Short Interest & Short Volume
7.81 days to coverFINRA reported short interest of 2,017,619 shares in FLGT as of the October 30, 2026 settlement, a 5.4% decrease from the prior period — about 7.8 days to cover at its recent average daily volume. On November 20, 2026, 49.0% of FLGT volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.